133 filings
Page 3 of 7
6-K
OPT
Opthea Limited
7 Mar 23
Current report (foreign)
6:01am
6-K
OPT
Opthea Limited
6 Mar 23
Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference
6:02am
6-K
OPT
Opthea Limited
23 Feb 23
Current report (foreign)
6:03am
SC 13G/A
OPT
Opthea Limited
15 Feb 23
Opthea / Regal Partners ownership change
6:01am
SC 13G/A
OPT
Opthea Limited
14 Feb 23
Opthea / BAKER BROS. ADVISORS ownership change
4:00pm
6-K
OPT
Opthea Limited
13 Feb 23
Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology
6:03am
6-K
OPT
Opthea Limited
6 Feb 23
Opthea To Present at SVB Leerink Global Biopharma Conference
6:02am
6-K
OPT
Opthea Limited
30 Jan 23
Opthea To Present at Sequire Biotechnology Conference
6:02am
6-K
OPT
Opthea Limited
11 Jan 23
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
12 Dec 22
Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
6:04am
6-K
OPT
Opthea Limited
6 Dec 22
Current report (foreign)
6:02am
6-K
OPT
Opthea Limited
16 Nov 22
Current report (foreign)
4:18pm
6-K
OPT
Opthea Limited
10 Nov 22
Opthea to Present at Jefferies London Healthcare Conference
4:17pm
6-K
OPT
Opthea Limited
24 Oct 22
Current report (foreign)
6:01am
20-F
2022 FY
OPT
Opthea Limited
Annual report (foreign)
29 Sep 22
11:09am
6-K
OPT
Opthea Limited
26 Sep 22
Market Announcements Office
4:15pm
6-K
OPT
Opthea Limited
30 Aug 22
Opthea Reports Fiscal Year 2022 Financial Results and Corporate Highlights
7:02am
6-K
OPT
Opthea Limited
26 Aug 22
Notice of Extraordinary General Meeting and Explanatory Notes
4:31pm
6-K
OPT
Opthea Limited
25 Aug 22
Current report (foreign)
4:30pm
6-K
OPT
Opthea Limited
15 Aug 22
Opthea Secures up to US$170 Million in Non-Dilutive Financing for OPT-302 in wet AMD
6:08am